Does anybody have the source or can they point me in the direction of proof of the apparent discrepancy over whether the company asked for 3, 4 doses in CD12 trial, like was used and endorsed by B.P., and Dr. Lalezari based on EIND experience, and the FDA stating that 2 doses would be sufficient (not allowing 4 doses in the trial)?